Cyclobenzaprine Hydrochloride
CYCLOBENZAPRINE HYDROCHLORIDE TABLETS, USP Rx only
Approved
Approval ID
19dd144a-db95-47f2-8e91-a1239a475fc1
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 1, 2020
Manufacturers
FDA
Innovida Pharmaceutique Corporation
DUNS: 080892908
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cyclobenzaprine Hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71800-003
Application NumberANDA078722
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cyclobenzaprine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateOctober 23, 2019
FDA Product Classification
INGREDIENTS (9)
CYCLOBENZAPRINE HYDROCHLORIDEActive
Quantity: 7.5 mg in 1 1
Code: 0VE05JYS2P
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT